Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

6
Number of overlapping holdings
22.2%
% of MEDX's 32 holdings also in IHE
17.6%
% of IHE's 34 holdings also in MEDX
Overlap by Weight
Sector Drift (MEDX minus IHE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in MEDX |
Weight in IHE |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 11.7% | 26.1% | 11.7% | |
JOHNSON & JOHNSON | 5.1% | 23.4% | 5.1% | |
PFIZER INC | 4.6% | 4.3% | 4.3% | |
BRISTOL-MYERS SQUIBB CO | 5.1% | 4.1% | 4.1% | |
MERCK & CO. INC. | 4.0% | 4.7% | 4.0% |
Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to IHE
ABBVIE INC | 6.2% | |
NOVARTIS AG-ADR | 5.5% | |
AMGEN INC | 5.2% | |
ASTRAZENECA PLC-SPONS ADR | 4.7% | |
CRISPR THERAPEUTICS AG | 4.4% | |
BIOGEN IDEC INC | 4.2% | |
GILEAD SCIENCES INC | 3.8% | |
IONIS PHARMACEUTICALS, INC. | 3.6% | |
SANOFI-AVENTIS-ADR | 3.4% | |
REGENERON PHARMACEUTICALS | 3.4% |
MEDX Underweight Relative to IHE
JOHNSON & JOHNSON | -18.3% | |
ELI LILLY & CO | -14.4% | |
ZOETIS INC | -4.7% | |
ROYALTY PHARMA PLC CLASS A | -4.6% | |
VIATRIS, INC. | -4.3% | |
JAZZ PHARMACEUTICALS PLC | -3.4% | |
CATALENT INC | -3.1% | |
ELANCO ANIMAL HEALTH, INC. | -2.6% | |
INTRA-CELLULAR THERAPIES INC | -2.3% | |
PERRIGO CO | -1.8% |